Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability

scientific article

Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/AJE/KWR439
P8608Fatcat IDrelease_dla6c2m6jzdjlhgobvhomivqdi
P932PMC publication ID3271817
P698PubMed publication ID22247047
P5875ResearchGate publication ID221749329

P50authorDonna BairdQ97362625
P2093author name stringAnne Z Steiner
P2860cites workAntimüllerian hormone as a predictor of natural fecundability in women aged 30-42 yearsQ23910016
Prospective assessment of fecundability of female semiconductor workersQ23910490
Reducing unintended pregnancy in the United StatesQ28261251
The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 yearsQ28395441
The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trialQ33616835
Reporting errors in time-to-pregnancy data collected with a short questionnaire. Impact on power and estimation of fecundability ratiosQ33634977
Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility.Q33982538
Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory womenQ34187352
Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal studyQ34410229
Validity of self-reported time to pregnancyQ34485478
Variations in serum müllerian inhibiting substance between white, black, and Hispanic women.Q34568747
Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual periodQ35811703
Environmental and occupational factors affecting fertility and IVF successQ35985646
Design and analysis of time-to-pregnancyQ36449447
Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transitionQ36938334
An internet-based prospective study of body size and time-to-pregnancy.Q37479057
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).Q37606149
The adverse effects of obesity on conception and implantationQ37731767
The journey from the old to the new AMH assay: how to avoid getting lost in the valuesQ37923047
Infertility among women exposed prenatally to diethylstilbestrol.Q38456599
Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancerQ39782486
Tobacco use, alcohol consumption and infertilityQ40273246
Cigarette smoking associated with delayed conceptionQ41498815
Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.Q43180203
Antimüllerian hormone serum levels: a putative marker for ovarian agingQ43872554
The Dalkon Shield sagaQ43935887
Use of time to pregnancy to study environmental exposuresQ44549160
Anti-Müllerian hormone concentrations in maternal serum during pregnancy.Q45285273
Prolonged time to pregnancy in residents exposed to ionising radiation in cobalt-60-contaminated buildings.Q45866891
Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroidsQ46963807
The risk of infertility and delayed conception associated with exposures in the Danish workplace.Q50554414
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.Q51032507
Serum anti-Mullerian hormone throughout the human menstrual cycle.Q51789873
Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.Q51798174
Using infertile patients in epidemiologic studies on subfecundity and embryonal loss.Q52040935
Sources of bias in studies of time to pregnancy.Q52882278
Feasibility of the current-duration approach to studying human fecundity.Q53004929
Serum Levels of Anti-Müllerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome PatientsQ57402015
Validity Issues Relating to Time-to-Pregnancy Studies of FertilityQ57420041
Has Human Fertility Declined Over Time?Q57420044
The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variabilityQ58376346
Longitudinal assessment of antimüllerian hormone during pregnancy—relationship with maternal adiposity, insulin, and adiponectinQ61847480
Prolonged Time to Pregnancy in Female Workers Exposed to Ethylene Glycol Ethers in Semiconductor ManufacturingQ61851069
Primary tubal infertility in relation to the use of an intrauterine deviceQ70063811
Tubal infertility and the intrauterine deviceQ70063814
The relation of obesity to menstrual disturbancesQ76190398
Validity of self-reported time to pregnancyQ82241954
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United StatesQ82444629
Heterogeneity in fecundability studies: issues and modellingQ83156642
Fertility and ovarian function in high-dose estrogen-treated tall womenQ83356669
Antimüllerian hormone and polycystic ovary syndromeQ84056753
Correlation of ovarian reserve tests with histologically determined primordial follicle numberQ84351138
Development of a second generation anti-Müllerian hormone (AMH) ELISAQ84963686
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)245-249
P577publication date2012-01-12
P1433published inAmerican Journal of EpidemiologyQ4744243
P1476titleAnti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability
P478volume175

Reverse relations

cites work (P2860)
Q33924350Active and passive smoking and fecundability in Danish pregnancy planners
Q28394989Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women
Q58352100Anti-Mullerian hormone and risk of invasive serous ovarian cancer
Q35269307Anti-Müllerian hormone and lifestyle, reproductive, and environmental factors among women in rural South Africa
Q51127348Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study.
Q64126132Anti-Müllerian hormone levels in nurses working night shifts
Q35890023Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women's Study.
Q98946602Association between a history of depression and anti-müllerian hormone among late-reproductive aged women: the Harvard study of moods and cycles
Q28387318Association between serum 25-hydroxyvitamin D and ovarian reserve in premenopausal women
Q46065513Best Practices in Counseling Young Female Cancer Survivors on Reproductive Health
Q40375111Cross-sectional study of the ultrasonographic and hormonal characteristics of obstetric fistula patients with and without secondary amenorrhea
Q50047483Evaluating the effects of administration of 25-hydroxyvitamin D supplement on serum anti-mullerian hormone (AMH) levels in infertile women
Q93335254Oncofertility: Meeting the Fertility Goals of Adolescents and Young Adults With Cancer
Q89980600Parameters of ovarian reserve in relation to urinary concentrations of parabens
Q37512512Possible role of autoimmunity in patients with premature ovarian insufficiency
Q48141819The Fertility Assessment and Counseling Clinic - does the concept work? A prospective 2-year follow-up study of 519 women
Q28278102The ageing ovary and uterus: new biological insights
Q48567619The influence of AMH on IVF success

Search more.